Eva Rivero‐Buceta
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
- Virology top 10%
- HIV Research and Treatment
Papers in
-
- Glycosylation and Glycoproteins Research 2
- RNA Interference and Gene Delivery 2
- Co-authors
- Pablo Botella (13 shared papers)Victoria Moreno‐Manzano (4 shared papers)Eduardo Fernández (4 shared papers)C.D. Vera Donoso (2 shared papers)Avelino Corma (1 shared paper)Ana San‐Félix (7 shared papers)Ernesto Quesada (6 shared papers)Christopher C. Landry (3 shared papers)
- Journals
- European Journal of Medicinal Chemistry (3 papers)ACS Omega (2 papers)Nanomaterials (2 papers)Nanoscale (2 papers)Pharmaceutics (1 paper)
- Partner nations
- SpainBelgiumUnited States
In The Last Decade
Eva Rivero‐Buceta
20 papers receiving 481 citations
Peers
Comparison fields: 5 of 70
- Biomaterials 170
- Virology 31
- Inorganic Chemistry 70
- Biomedical Engineering 168
- Pharmaceutical Science 16
Countries citing papers authored by Eva Rivero‐Buceta
This map shows the geographic impact of Eva Rivero‐Buceta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Rivero‐Buceta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Rivero‐Buceta more than expected).
Fields of papers citing papers by Eva Rivero‐Buceta
This network shows the impact of papers produced by Eva Rivero‐Buceta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Rivero‐Buceta. The network helps show where Eva Rivero‐Buceta may publish in the future.
Co-authors
The 25 scholars most cited alongside Eva Rivero‐Buceta, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 91 | |
| 2 | 2019 | 54 | |
| 3 | 2019 | 48 | |
| 4 | 2019 | 39 | |
| 5 | 2022 | 36 | |
| 6 | 2015 | 34 | |
| 7 | 2019 | 26 | |
| 8 | 2015 | 25 | |
| 9 | 2020 | 19 | |
| 10 | 2016 | 18 | |
| 11 | 2016 | 17 | |
| 12 | 2018 | 16 | |
| 13 | 2021 | 13 | |
| 14 | 2012 | 11 | |
| 15 | 2015 | 10 | |
| 16 | 2023 | 9 | |
| 17 | 2024 | 8 | |
| 18 | 2022 | 6 | |
| 19 | 2021 | 3 | |
| 20 | 2025 | 2 |
About Eva Rivero‐Buceta
Eva Rivero‐Buceta is a scholar working on Molecular Biology, Materials Chemistry, Biomaterials, Biomedical Engineering and Virology, having authored 20 papers that have together received 485 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (5 papers), Nanoplatforms for cancer theranostics (5 papers), HIV Research and Treatment (4 papers), Viral Infections and Immunology Research (3 papers), Glycosylation and Glycoproteins Research (2 papers), Metal-Organic Frameworks: Synthesis and Applications (2 papers), RNA Interference and Gene Delivery (2 papers) and Carbohydrate Chemistry and Synthesis (2 papers). The work is most often cited by research in Biomaterials (170 citations), Virology (31 citations), Inorganic Chemistry (70 citations), Biomedical Engineering (168 citations) and Pharmaceutical Science (16 citations). Eva Rivero‐Buceta has collaborated with scholars based in Spain, Belgium and United States. Frequent co-authors include Pablo Botella, Victoria Moreno‐Manzano, Eduardo Fernández, C.D. Vera Donoso, Avelino Corma, Ana San‐Félix, Ernesto Quesada, Christopher C. Landry, María‐José Camarasa and J. Benlloch. Their work appears in journals such as European Journal of Medicinal Chemistry, ACS Omega, Nanomaterials, Nanoscale and Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.